Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Introduction: Postmarketing data on outcomes of avacopan use in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) are lacking. Methods: We performed a multicenter retrospective analysis of 92 patients with newly diagnosed or relapsing AAV who received therapy with avacopan....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Reza Zonozi, Faten Aqeel, Dustin Le, Frank B. Cortazar, Jugal Thaker, Maria Jose Zabala Ramirez, Sebastian Eduardo Sattui Cortes, Rose Mary Attieh, Madeline Chung, David H. Bulbin, Aisha Shaikh, Karina Guaman, Julia Ford, Colin Diffie, Ora Gewurz-Singer, Gabriel Sauvage, Anushya Jeyabalan, Abdallah Geara, Isabelle Ayoub, Andrew Bomback, Lara L. Khoury, Jason C. George, Kenar D. Jhaveri, Vimal Kumar Derebail, John L. Niles, Duvuru Geetha
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2024-06-01
Reeks:Kidney International Reports
Onderwerpen:
avacopan
ANCA-associated vasculitis
complement
remission
kidney recovery
Online toegang:http://www.sciencedirect.com/science/article/pii/S246802492401605X
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items